AnwaltssucheUnsere KompetenzenDeine Karriere
Standorte
Unsere Kompetenzen
Media Center

Select language:

Standorte
Unsere Kompetenzen
Media Center

Select language:

hamburger menu showcase image
New York
Max Sanders
Senior Associate
max.sanders@freshfields.com
New York: +1 212 277 4000
hero-banner-image
About

Max is a senior associate in our Global Transactions group focusing on cross-border mergers and acquisitions and commercial transactions.

Capabilities
Intellectual property
Mergers and acquisitions
Connect
Email
VCARD
Download
Additional Information

  • CK Life Sciences on its sale of Polynoma to TransCode Therapeutics.
  • McLaren on its acquisition of all shares in McLaren Racing held by its minority shareholders.
  • Merck on its pending $10 billion acquisition of Verona Pharma plc.‎
  • Sanofi S.A. on its pending acquisition of Vigil Neuroscience, Inc.  
  • Razor Group on its acquisition of Perch.
  • BuzzFeed on its sale of Complex Networks to Commerce Media.
  • London Stock Exchange Group on its acquisition of AcadiaSoft.
  • Agilent on its sale of Resolution Bioscience.
  • Molekule Group, Inc. on its all-Stock merger with Aura Smart Air Ltd.
  • Zymergen Inc. on its acquisition of Lodo Therapeutics Corporation.
  • Sitel Group on its $2.2 billion take-private of Sykes Enterprises.
  • Röhm on its acquisition of SABIC's Functional Forms Business.
  • América Móvil on its sale of Claro Panama to Liberty Latin America affiliate.
  • Stagwell Media on its combination with MDC Partners.
  • Google on its $4.5bn transaction with Jio Platforms, including commercial agreements to develop an affordable smartphone with an optimized operating system.
  • CVC Capital on its $470 million minority investment in Aleph Holding.
  • An American pharmaceutical and biotechnology company on its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA manufacturing facility at Monash University.
  • General Dynamics Land Systems on its investment in Epirus, Inc.
  • Hewlett Packard Enterprise in acquisition of Determined AI.
  • Royal Caribbean on the carve-out sale of its high-end cruise business, Azamara, to Sycamore Partners.
  • Airbus on its joint venture with Bombardier regarding the “C Series” (now “A220”) aircraft program and on the subsequent exit of Bombardier from the joint venture.
  • CVC Capital Partners on its $1.37 billion acquisition of Ontic, a provider of OEM-licensed parts for legacy aerospace platforms, from BBA Aviation.
  • Novartis on its $5.3 billion acquisition of the Xiidra® business from Shire North American Group.
  • A multinational chemicals company on its €7.6 billion acquisition of significant components of Bayer’s and Monsanto’s seed, agricultural and chemical businesses.
  • Starbucks Corporation on its $7.15 billion global coffee alliance with Nestlé.
  • ABB on its $7.8 billion sale of its power grids business to a joint venture with Hitachi.
  • Continental AG on its $266 million acquisition of Cooper-Standard Automotive Inc.’s anti-vibration systems business.
  • Catalent on its acquisition of a pharmaceutical manufacturing facility in Anagni, Italy from Bristol-Myers Squibb.
  • International General Insurance on its Nasdaq listing, PIPE capital raise and merger with SPAC Tiberius Acquisition Corp.
  • KLX Inc. on the $4.2 billion take-private of its Aerospace Solutions Group by The Boeing Company and on the spin-off of its Energy Services Group (now KLX Energy Services) to KLX shareholders.

Max Sanders
Senior Associate
max.sanders@freshfields.com

T +1 212 277 4000

New York Office

3 World Trade Center

175 Greenwich Street, 51st Floor

10007 New York
Download vCard
FINDEN SIE UNS IN
Standorte
NAVIGIEREN ZU
Über unsDeine KarriereUnser DenkenUnsere KompetenzenMedia Center
KONTAKT
AnwaltssucheAlumniKontakt
HILFE
Betrug und BetrugsversucheBeschwerde- management
RECHTLICHES
BarrierefreiheitRechtliche Hinweise DeutschlandRechtliche Hinweise ÖsterreichCookiesLieferketten- transparenzBeschaffungDatenschutz

© 2025 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome

Select language: